80 research outputs found
A MACHINE LEARNING APPROACH TO QUERY TIME-SERIES MICROARRAY DATA SETS FOR FUNCTIONALLY RELATED GENES USING HIDDEN MARKOV MODELS
Microarray technology captures the rate of expression of genes under varying experimental conditions. Genes encode the information necessary to build proteins; proteins used by cellular functions exhibit higher rates of expression for the associated genes. If multiple proteins are required for a particular function then their genes show a pattern of coexpression during time periods when the function is active within a cell. Cellular functions are generally complex and require groups of genes to cooperate; these groups of genes are called functional modules. Modular organization of genetic functions has been evident since 1999. Detecting functionally related genes in a genome and detecting all genes belonging to particular functional modules are current research topics in this field. The number of microarray gene expression datasets available in public repositories increases rapidly, and advances in technology have now made it feasible to routinely perform whole-genome studies where the behavior of every gene in a genome is captured. This promises a wealth of biological and medical information, but making the amount of data accessible to researchers requires intelligent and efficient computational algorithms. Researchers working on specific cellular functions would benefit from this data if it was possible to quickly extract information useful to their area of research. This dissertation develops a machine learning algorithm that allows one or multiple microarray data sets to be queried with a set of known and functionally related input genes in order to detect additional genes participating in the same or closely related functions. The focus is on time-series microarray datasets where gene expression values are obtained from the same experiment over a period of time from a series of sequential measurements. A feature selection algorithm selects relevant time steps where the provided input genes exhibit correlated expression behavior. Time steps are the columns in microarray data sets, rows list individual genes. A specific linear Hidden Markov Model (HMM) is then constructed to contain one hidden state for each of the selected experiments and is trained using the expression values of the input genes from the microarray. Given the trained HMM the probability that a sequence of gene expression values was generated by that particular HMM can be calculated. This allows for the assignment of a probability score for each gene in the microarray. High-scoring genes are included in the result set (of genes with functional similarities to the input genes.) P-values can be calculated by repeating this algorithm to train multiple individual HMMs using randomly selected genes as input genes and calculating a Parzen Density Function (PDF) from the probability scores of all HMMs for each gene. A feedback loop uses the result generated from one algorithm run as input set for another iteration of the algorithm. This iterated HMM algorithm allows for the characterization of functional modules from very small input sets and for weak similarity signals. This algorithm also allows for the integration of multiple microarray data sets; two approaches are studied: Meta-Analysis (combination of the results from individual data set runs) and the extension of the linear HMM across multiple individual data sets. Results indicate that Meta-Analysis works best for integration of closely related microarrays and a spanning HMM works best for the integration of multiple heterogeneous datasets. The performance of this approach is demonstrated relative to the published literature on a number of widely used synthetic data sets. Biological application is verified by analyzing biological data sets of the Fruit Fly D. Melanogaster and Bakerâs Yeast S. Cerevisiae. The algorithm developed in this dissertation is better able to detect functionally related genes in common data sets than currently available algorithms in the published literature
Requirements analysis document
This document details the purpose, features, and expected interfaces for the complete EXCELERATE WP9 (Use Case D: ELIXIR framework for secure archiving, dissemination and analysis of human access-controlled data). It outlines the tasks the system will perform, the constraints under which it operates, and how it reacts in certain circumstances. This document is intended for stakeholders, designers and developers as well as users of the system, and derives from a joint analysis carried out with these groups
htsget: a protocol for securely streaming genomic data
Summary:
Standardized interfaces for efficiently accessing high-throughput sequencing data are a fundamental requirement for large-scale genomic data sharing. We have developed htsget, a protocol for secure, efficient and reliable access to sequencing read and variation data. We demonstrate four independent client and server implementations, and the results of a comprehensive interoperability demonstration.
Availability and implementation:
http://samtools.github.io/hts-specs/htsget.html
Supplementary information:
Supplementary data are available at Bioinformatics online
A BalkĂĄn Ă©s az OszmĂĄn Birodalom III. : TĂĄrsadalmi Ă©s gazdasĂĄgi ĂĄtalakulĂĄsok a 18. szĂĄzad vĂ©gĂ©tĆl a 20. szĂĄzad közepĂ©ig : Szerbia, MacedĂłnia, Bosznia
High-throughput molecular profiling techniques are routinely generating vast amounts of data for translational medicine studies. Secure access controlled systems are needed to manage, store, transfer and distribute these data due to its personally identifiable nature. The European Genome-phenome Archive (EGA) was created to facilitate access and management to long-term archival of bio-molecular data. Each data provider is responsible for ensuring a Data Access Committee is in place to grant access to data stored in the EGA. Moreover, the transfer of data during upload and download is encrypted. ELIXIR, a European research infrastructure for life-science data, initiated a project (2016 Human Data Implementation Study) to understand and document the ELIXIR requirements for secure management of controlled-access data. As part of this project, a full ecosystem was designed to connect archived raw experimental molecular profiling data with interpreted data and the computational workflows, using the CTMM Translational Research IT (CTMM-TraIT) infrastructure http://www.ctmm-trait.nl as an example. Here we present the first outcomes of this project, a framework to enable the download of EGA data to a Galaxy server in a secure way. Galaxy provides an intuitive user interface for molecular biologists and bioinformaticians to run and design data analysis workflows. More specifically, we developed a tool -- ega_download_streamer - that can download data securely from EGA into a Galaxy server, which can subsequently be further processed. This tool will allow a user within the browser to run an entire analysis containing sensitive data from EGA, and to make this analysis available for other researchers in a reproducible manner, as shown with a proof of concept study. The tool ega_download_streamer is available in the Galaxy tool shed: https://toolshed.g2.bx.psu.edu/view/yhoogstrate/ega_download_streamer
GA4GH: International policies and standards for data sharing across genomic research and healthcare.
The Global Alliance for Genomics and Health (GA4GH) aims to accelerate biomedical advances by enabling the responsible sharing of clinical and genomic data through both harmonized data aggregation and federated approaches. The decreasing cost of genomic sequencing (along with other genome-wide molecular assays) and increasing evidence of its clinical utility will soon drive the generation of sequence data from tens of millions of humans, with increasing levels of diversity. In this perspective, we present the GA4GH strategies for addressing the major challenges of this data revolution. We describe the GA4GH organization, which is fueled by the development efforts of eight Work Streams and informed by the needs of 24 Driver Projects and other key stakeholders. We present the GA4GH suite of secure, interoperable technical standards and policy frameworks and review the current status of standards, their relevance to key domains of research and clinical care, and future plans of GA4GH. Broad international participation in building, adopting, and deploying GA4GH standards and frameworks will catalyze an unprecedented effort in data sharing that will be critical to advancing genomic medicine and ensuring that all populations can access its benefits
Solving unsolved rare neurological diseases-a Solve-RD viewpoint.
Funder: Durch Princess Beatrix Muscle Fund Durch Speeren voor Spieren Muscle FundFunder: University of TĂŒbingen Medical Faculty PATE programFunder: European Reference Network for Rare Neurological Diseases | 739510Funder: European Joint Program on Rare Diseases (EJP-RD COFUND-EJP) | 44140962
Solve-RD: systematic pan-European data sharing and collaborative analysis to solve rare diseases.
For the first time in Europe hundreds of rare disease (RD) experts team up to actively share and jointly analyse existing patient's data. Solve-RD is a Horizon 2020-supported EU flagship project bringing together >300 clinicians, scientists, and patient representatives of 51 sites from 15 countries. Solve-RD is built upon a core group of four European Reference Networks (ERNs; ERN-ITHACA, ERN-RND, ERN-Euro NMD, ERN-GENTURIS) which annually see more than 270,000 RD patients with respective pathologies. The main ambition is to solve unsolved rare diseases for which a molecular cause is not yet known. This is achieved through an innovative clinical research environment that introduces novel ways to organise expertise and data. Two major approaches are being pursued (i) massive data re-analysis of >19,000 unsolved rare disease patients and (ii) novel combined -omics approaches. The minimum requirement to be eligible for the analysis activities is an inconclusive exome that can be shared with controlled access. The first preliminary data re-analysis has already diagnosed 255 cases form 8393 exomes/genome datasets. This unprecedented degree of collaboration focused on sharing of data and expertise shall identify many new disease genes and enable diagnosis of many so far undiagnosed patients from all over Europe
Solving patients with rare diseases through programmatic reanalysis of genome-phenome data.
Funder: EC | EC Seventh Framework Programm | FP7 Health (FP7-HEALTH - Specific Programme "Cooperation": Health); doi: https://doi.org/10.13039/100011272; Grant(s): 305444, 305444Funder: Ministerio de EconomĂa y Competitividad (Ministry of Economy and Competitiveness); doi: https://doi.org/10.13039/501100003329Funder: Generalitat de Catalunya (Government of Catalonia); doi: https://doi.org/10.13039/501100002809Funder: EC | European Regional Development Fund (Europski Fond za Regionalni Razvoj); doi: https://doi.org/10.13039/501100008530Funder: Instituto Nacional de BioinformĂĄtica ELIXIR Implementation Studies Centro de Excelencia Severo OchoaFunder: EC | EC Seventh Framework Programm | FP7 Health (FP7-HEALTH - Specific Programme "Cooperation": Health)Reanalysis of inconclusive exome/genome sequencing data increases the diagnosis yield of patients with rare diseases. However, the cost and efforts required for reanalysis prevent its routine implementation in research and clinical environments. The Solve-RD project aims to reveal the molecular causes underlying undiagnosed rare diseases. One of the goals is to implement innovative approaches to reanalyse the exomes and genomes from thousands of well-studied undiagnosed cases. The raw genomic data is submitted to Solve-RD through the RD-Connect Genome-Phenome Analysis Platform (GPAP) together with standardised phenotypic and pedigree data. We have developed a programmatic workflow to reanalyse genome-phenome data. It uses the RD-Connect GPAP's Application Programming Interface (API) and relies on the big-data technologies upon which the system is built. We have applied the workflow to prioritise rare known pathogenic variants from 4411 undiagnosed cases. The queries returned an average of 1.45 variants per case, which first were evaluated in bulk by a panel of disease experts and afterwards specifically by the submitter of each case. A total of 120 index cases (21.2% of prioritised cases, 2.7% of all exome/genome-negative samples) have already been solved, with others being under investigation. The implementation of solutions as the one described here provide the technical framework to enable periodic case-level data re-evaluation in clinical settings, as recommended by the American College of Medical Genetics
From Romantic Gothic to Victorian Medievalism: 1817 and 1877
"The Cambridge History of the Gothic was conceived in 2015, when Linda Bree, then Editorial Director at Cambridge University Press, first suggested the idea to us
- âŠ